Note 3 - Net Loss Per Share

6 Months Ended

Jun. 30, 2018

Notes to Financial Statements

Earnings Per Share [Text Block]

Note

3

. Net

Loss

Per Share

Our basic net loss per share amounts have been computed by dividing net loss by the weighted-average number of common shares outstanding during the period. For the

three

and

six

months ended

June 30, 2018

and

2017,

we reported net losses and, accordingly, potential common shares were

not

included since such inclusion would have been anti-dilutive.

The calculations of net loss per share, basic and diluted, are as follows (amounts in thousands, except per share data):

	Net Loss			Weighted-Average
	Attributable			Shares
	to Progenics			Outstanding		Per Share
	(Numerator)			(Denominator)		Amount
Three months ended June 30, 2018
Basic and diluted	$	(15,172	)		74,017	$	(0.20	)
Six months ended June 30, 2018
Basic and diluted	$	(28,596	)		73,271	$	(0.39	)
Three months ended June 30, 2017
Basic and diluted	$	(16,636	)		70,202	$	(0.24	)
Six months ended June 30, 2017
Basic and diluted	$	(32,996	)		70,214	$	(0.47	)

The following table summarizes anti-dilutive common shares or common shares where performance conditions have

not

been met, that were excluded from the calculation of diluted net loss per share (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2018		2017		2018		2017
Stock options		3,237		2,971		3,236		1,614
Contingent consideration liability		2,351		2,474		2,351		2,474
Total securities excluded		5,588		5,445		5,587		4,088